ArticleIBRO neuroscience reports2026
Behavioural, neurochemical, and neurohistological effects of bisphenol A and vanadium following chronic co-administration in mice.
Article in IBRO neuroscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bisphenol A (BPA) and vanadium are industrial chemicals known to disrupt hormones and cause neurotoxicity. BPA is commonly found in food packaging and poses risks to human health through various exposure routes, while vanadium exposure can occur near power plants. Both chemicals induce oxidative stress, disrupt neurotransmission, and cause neuronal damage, yet research on their combined effects is limited. To examine the behavioral, neurochemical, and neurohistological changes associated with co-exposure to BPA and vanadium, we utilized 40 male BALB/c mice, divided into four groups: the control group, the BPA-exposed group, the vanadium-exposed group, and the BPA + vanadium co-exposed group. Mice in the control group received dimethyl sulfoxide (DMSO) only. The BPA-exposed group was administered 10 µg/kg bw/day of BPA, while the vanadium-exposed group received 1.2 mg/kg bw/day of vanadyl sulphate. Mice in the BPA + vanadium co-exposed group received both 10 µg/kg bw/day of BPA and 1.2 mg/kg bw/day of vanadyl sulphate. Each group underwent this oral administration daily for 56 consecutive days. Moreover, we conducted behavioral, histological and neurochemical analyses on the prefrontal cortex of the mice. Our findings revealed that co-exposure to BPA and vanadium significantly exacerbated impairments in behavioral and neurochemical indicators. Notably, the histoarchitectural profile of the prefrontal cortex indicated evidence of neuronal cell death. In conclusion, our study suggests that co-exposure to BPA and vanadium correlates with detrimental effects on behaviors associated with the prefrontal cortex, alongside substantial neurochemical disruptions and compromised structural integrity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.